Vaccination Against COVID-19 in Chronic Kidney Disease
Observational Study on the Effects of SARS-CoV-2 Vaccination in Dialysis and Kidney Transplant Patients
Sponsor: Heinrich-Heine University, Duesseldorf
Listed as NCT04743947, this observational or N/A phase trial focuses on Chronic Kidney Disease Stage 5 With Transplant and Chronic Kidney Disease Stage 5 on Dialysis and remains ongoing. Sponsored by Heinrich-Heine University, Duesseldorf, it has been updated 5 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Feb 2026 — Present [monthly]
Unknown
Status: Recruiting → Unknown
-
Sep 2024 — Feb 2026 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Feb 2022 — Jul 2024 [monthly]
Recruiting
-
Mar 2021 — Feb 2022 [monthly]
Recruiting
First recorded
Dec 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Heinrich-Heine University, Duesseldorf
For direct contact, visit the study record on ClinicalTrials.gov .